Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B
在健康受试者和乙型肝炎患者中进行的 I 期研究，评估了衣壳抑制剂 AB-506 的安全性、药代动力学和抗病毒活性。
期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.2095
Yuen, Man-Fung; Berliba, Elina; Sukeepaisarnjaroen, Wattana; Ahn, Sang Hoon; Tanwandee, Tawesak; Lim, Young-Suk; Kim, Yoon Jun; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Schwabe, Christian; Eley, Timothy; Brown, Joanne; Lee, Amy C H; Thi, Emily P; Paratala, Bhavna; Mani, Nagraj; Sofia, Michael J; Picchio, Gaston; Sims, Karen D; Gane, Edward J
